AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Amylyx Pharmaceuticals
AMLX
$2.26B
| $1.02M | ﹤0.01% |
36,242
+342
| +1% | +$8.53K |
|
2277
BP
BP
$116B
| $1.02M | ﹤0.01% |
+35,733
| New | +$1.06M |
|
2278
Aurinia Pharmaceuticals
AUPH
$1.91B
| $1.02M | ﹤0.01% |
135,500
| – | – |
|
|
SWTX
2279
DELISTED
SpringWorks Therapeutics
SWTX
| $1.02M | ﹤0.01% |
35,700
| – | – |
|
|
VTLE
2280
DELISTED
Vital Energy
VTLE
| $1.01M | ﹤0.01% |
16,109
+396
| +3% | +$28.2K |
|
2281
Editas Medicine
EDIT
$396M
| $1.01M | ﹤0.01% |
82,500
| – | – |
|
2282
Photronics
PLAB
$1.79B
| $1.01M | ﹤0.01% |
68,987
+61
| +0.1% | +$1.2K |
|
2283
Krispy Kreme
DNUT
$548M
| $1.01M | ﹤0.01% |
87,378
| – | – |
|
2284
Crinetics Pharmaceuticals
CRNX
$8.84B
| $1.01M | ﹤0.01% |
51,200
| – | – |
|
|
INVX
2285
Innovex International
INVX
$1.96B
| $1M | ﹤0.01% |
51,403
+262
| +0.5% | +$6.07K |
|
2286
Coupang
CPNG
$29.3B
| $1M | ﹤0.01% |
+60,101
| New | +$1.04M |
|
2287
Simulations Plus
SLP
$369M
| $999K | ﹤0.01% |
20,591
+3,499
| +20% | +$204K |
|
|
AVTA
2288
DELISTED
Avantax, Inc. Common Stock
AVTA
| $995K | ﹤0.01% |
51,428
+134
| +0.3% | +$2.69K |
|
|
RTL
2289
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $995K | ﹤0.01% |
169,301
-9,249
| -5% | -$68.4K |
|
2290
Astec Industries
ASTE
$1.16B
| $993K | ﹤0.01% |
31,839
+17
| +0.1% | +$691 |
|
|
BLUA
2291
DELISTED
BlueRiver Acquisition Corp.
BLUA
| $990K | ﹤0.01% |
100,000
| – | – |
|
2292
E.W. Scripps
SSP
$257M
| $988K | ﹤0.01% |
87,710
+1,890
| +2% | +$26.8K |
|
2293
Energy Fuels
UUUU
$2.86B
| $988K | ﹤0.01% |
161,400
+10,900
| +7% | +$69.7K |
|
2294
MasterCraft Boat Holdings
MCFT
$579M
| $986K | ﹤0.01% |
52,285
| – | – |
|
2295
Instil Bio
TIL
$48.3M
| $985K | ﹤0.01% |
10,179
+430
| +4% | +$49.2K |
|
2296
Perimeter Solutions
PRM
$4.99B
| $979K | ﹤0.01% |
122,200
| – | – |
|
2297
DHT Holdings
DHT
$2.99B
| $977K | ﹤0.01% |
129,200
+21,500
| +20% | +$161K |
|
|
AMWD
2298
DELISTED
American Woodmark
AMWD
| $973K | ﹤0.01% |
22,189
+25
| +0.1% | +$1.22K |
|
2299
Home Federal Bancorp
HFBL
$71.3M
| $973K | ﹤0.01% |
52,002
+2,936
| +6% | +$58.9K |
|
2300
National Healthcare
NHC
$3.53B
| $971K | ﹤0.01% |
15,336
| – | – |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.